Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Casodex

Known as: AstraZeneca brand of bicalutamide, Zeneca brand of bicalutamide, Astra brand of bicalutamide 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Despite the fact that androgen deprivation therapy (ADT) can effectively reduce prostate cancer (PCa) size, its effect on PCa… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Despite androgen deprivation therapy (ADT) suppression of prostate cancer (PCa) growth, its overall effects on PCa metastasis… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Although the androgen receptor (AR) is a known clinical target in prostate cancer, little is known about its possible role in… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2007
2007
Prostate tumors are initially dependent on androgens for growth, but the majority of patients treated with anti-androgen therapy… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2005
Highly Cited
2005
In this study, we show that androgens up-regulate insulin-like growth factor-I receptor (IGF-IR) expression and sensitize… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2000
Highly Cited
2000
An expression construct containing the cDNA encoding a modified aequorea green fluorescent protein (GFP) ligated to the 5'-end of… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Aberrant activation of the androgen receptor through signaling pathways independent of androgen may be responsible for the… Expand
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Abstract Aberrant activation of the androgen receptor (AR) may be one of the mechanisms which contribute to progression of… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Aberrant activation of the androgen receptor (AR) may be one of the mechanisms which contribute to progression of prostatic… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
OBJECTIVE To evaluate the relationship between antiandrogen withdrawal and change in prostate-specific antigen (PSA) when the… Expand
Is this relevant?